USE OF ACCELERATED LYMPHOCYTE HOMING AGENTS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DELAYED GRAFT FUNCTION

Details for Australian Patent Application No. 2002231810 (hide)

Owner NOVARTIS AG

Inventors SABLINSKI, Tomasz; BIGAUD, Marc; BRINKMANN, Volker

Pub. Number AU-A-2002231810

PCT Pub. Number WO2002/067915

Priority 0104438.7 22.02.01 GB; 0105000.4 28.02.01 GB

Filing date 21 February 2002

Wipo publication date 12 September 2002

International Classifications

A61K 031/133 - having hydroxy groups, e.g. sphingosine

A61K 031/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 031/201

A61P 037/06 Drugs for immunological or allergic disorders

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-A-2002231810

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002231811-Use of flumazenil to produce a medicament for the treatment of cocaine dependency

2002231809-SHIFTING UNIT FOR DISPLACING A CONVEYOR ROAD